Vertex Pharmaceuticals
VRTX
VRTX
1,542 hedge funds and large institutions have $107B invested in Vertex Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 118 funds opening new positions, 605 increasing their positions, 609 reducing their positions, and 146 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $115B → $107B (-$7.64B)
19% less first-time investments, than exits
New positions opened: 118 | Existing positions closed: 146
38% less funds holding in top 10
Funds holding in top 10: 26 → 16 (-10)
Holders
1,542
Holding in Top 10
16
Calls
$930M
Puts
$554M
Top Buyers
| 1 | +$884M | |
| 2 | +$836M | |
| 3 | +$700M | |
| 4 |
Jennison Associates
New York
|
+$485M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$226M |
Top Sellers
| 1 | -$898M | |
| 2 | -$840M | |
| 3 | -$588M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$330M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$286M |
